Zimmer Biomet Unveils Leadership Team Behind ZimVie Spinout

ZimVie is the combination of Zimmer Biomet’s dental and spine businesses. The spin-out is set to be completed by mid-2022.

Omar Ford

September 14, 2021

1 Min Read
IMG_Sep142021at14313PM.jpg
JHVEPhoto-stock.adobe.com

Zimmer Biomet has named its planned dental and spines spinout, ZimVie. The company also named the leadership team for the new company, which will officially be spun out by mid-2022.

Richard J. Heppenstall will serve as executive VP and CFO.

Warsaw, ID-based Zimmer Biomet executives first spoke about the spin-off-plan in early February.  The creation of ZimVie is the third phase of the company’s transformation.

In addition to Mr. Heppenstall, the following team members have been appointed to the ZimVie leadership team.

  • Vincent Binetti, General Manager, Bone Healing

  • Laura Driscoll, Vice President, Communications

  • David Harmon, Senior Vice President, Chief Human Resources Officer

  • Indraneel Kanaglekar, Senior Vice President, President, Global Dental

  • Heather Kidwell, Senior Vice President, Chief Legal and Compliance Officer

  • Mike Minette, Senior Vice President, Strategy and Corporate Development

  • Ann Vu, Senior Vice President, Regulatory Affairs and Quality Assurance

  • Rebecca Whitney, Senior Vice President, President, Global Spine

The seeds for ZimVie were planted when CEO Bryan Hanson took the helm at Zimmer Biomet in December 2017 and was tasked with righting the ship.

The company had struggled with quality control and supply chain problems for about a year at that point, and those challenges had created investor frustration that ultimately led to former CEO David Dvorak's resignation in July 2017.

In October 2018, Hanson told investors that Zimmer Biomet would have to reduce the size of its portfolio to simplify the supply chain and improve service levels to customers. 

 

 

About the Author

Omar Ford

Omar Ford is a veteran reporter in the field of medical technology and healthcare journalism. As Editor-in-Chief of MD+DI (Medical Device and Diagnostics Industry), a leading publication in the industry, Ford has established himself as an authoritative voice and a trusted source of information.

Ford, who has a bachelor's degree in print journalism from the University of South Carolina, has dedicated his career to reporting on the latest advancements and trends in the medical device and diagnostic sector.

During his tenure at MD+DI, Ford has covered a wide range of topics, including emerging medical technologies, regulatory developments, market trends, and the rise of artificial intelligence. He has interviewed influential leaders and key opinion leaders in the field, providing readers with valuable perspectives and expert analysis.

 

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like